Measures of Obesity and Co-Morbid Conditions in Maori

It has been proposed that a higher cut off for BMI (body mass index) is to be used in Maori to define overweight and obesity. However, no one has assessed the prevalence of co-morbid conditions associated with BMI. It is well known that Maori are at greater risk of diabetes and cardiovascular disease compared to non-Maori and a delay in the identification of those who are overweight and obese may be detrimental for Maori. We will assess BMI, other measures of adiposity and prevalence of co-morbid conditions with a comparison with a similar matched non-Maori population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Body Composition Cardiovascular Diseases Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–68 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Edgar National Centre for Diabetes Research

Dunedin, Otago, 9001, New Zealand

About this study

This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.

Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Self identify as Maori and non-Maori aged between 18-68 years
Male and female
Non-diabetic
Resident of Dunedin and Invercargill

Exclusion criteria

The presence of diabetes, renal or liver failure, or any other medical condition which is unstable and for which they are currently having active treatment

Sponsors and collaborators

Lead sponsor

Edgar National Centre for Diabetes Research

Other

Registry information

Important dates

Study start: 2003
Study completion: 2005
First posted: Sep 21, 2005
Registry last updated: Sep 21, 2005

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed